India, Oct. 19 -- Shares of Parabilis Medicines, Inc. (PBLS) are gaining 13 percent on Monday morning after the company shared its plans to present updated clinical data for zolucatetide in patients with desmoid tumors at the European Society for Medical Oncology Congress 2026.
The company's shares are currently trading at $25.88 on the Nasdaq, up 13.88 percent. The stock opened at $22.98 and has climbed as high as $26.24 so far in today's session. Over the past year, it has traded in a range of $22.66 to $42.49.
For comments and feedback contact: editorial@rttnews.com
Published by HT Digital Content Services with permission from RTT News....